Vaccination

Closing in on COVID-19 vaccine

South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 ...

Neuroscience

Study shows why even well-controlled epilepsy can disrupt thinking

A study by Stanford University School of Medicine investigators may help explain why even people benefiting from medications for their epilepsy often continue to experience bouts of difficulty thinking, perceiving and remembering ...

Diseases, Conditions, Syndromes

The role of T-cells in SARS-CoV-2 virus defense

Our immune system can efficiently fend off viral diseases. T-cells can directly destroy virus-infected cells and enable the formation of efficient, virus-neutralizing antibodies by B-cells. These two cell types also play ...

Neuroscience

'Happy ending effect' can bias future decisions, say scientists

Humans are hard-wired to prefer experiences that end well, and the influence of previous experience declines the longer ago it happened. This means we can't always trust that choices we make based on previous experience will ...

Diseases, Conditions, Syndromes

Sanofi, GSK say COVID-19 shot won't be ready until late 2021

Drugmakers Sanofi and GlaxoSmithKline said Friday that their potential COVID-19 vaccine won't be ready until late next year because they need to improve the shot's effectiveness in older people.

page 1 from 3